Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.03 0.00 (-13.33%)
As of: Oct 21, 2026 · 12:27 PM EDT

Adaptimmune Therapeutics PLC (ADAPY) Total Debt (2024 - 2025)

Updated

Adaptimmune Therapeutics' Total Debt came in at $25.68 million for Q2 2025, up 2.9% from $24.95 million a year earlier and up 1.0% from the prior quarter.

Analysis

Adaptimmune Therapeutics PLC (ADAPY) Total Debt (2024 - 2025) Analysis & Trends

At the end of FY2024, Adaptimmune Therapeutics' Total Debt was $50.24 million.

  • The five-year range for quarterly Total Debt is $24.95 million (Q2 2024) to $50.24 million (Q4 2024).
  • Business Quant data shows ADAPY's Total Debt at $25.41 million (Q1 2025), $50.24 million (Q4 2024) and $49.87 million (Q3 2024) in the three quarters before Q2 2025.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 25.68 Mn
Mar 31, 2025 25.41 Mn
Dec 31, 2024 50.24 Mn
Sep 30, 2024 49.87 Mn
Jun 30, 2024 24.95 Mn
API Access

Adaptimmune Therapeutics PLC Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ADAPY&period=max&api_key=YOUR_API_KEY